Cartesian Therapeutics, Inc. Finance Lease, Right-of-Use Asset, Amortization
Cartesian Therapeutics, Inc. (RNAC) reported Finance Lease, Right-of-Use Asset, Amortization of $477.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-06
- Cartesian Therapeutics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $242.00K, a 29.41% increase year-over-year.
- Cartesian Therapeutics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $235.00K, a 27.72% increase year-over-year.
- Cartesian Therapeutics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $215.00K, a 67.96% decline year-over-year.
- Cartesian Therapeutics, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $192.00K, a 70.60% decline year-over-year.
- Cartesian Therapeutics, Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $778.00K, a 68.08% decline from fiscal 2024.
- Cartesian Therapeutics, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $2.44M, a 38.94% increase from fiscal 2023.
- Cartesian Therapeutics, Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $1.75M, a 31.19% increase from fiscal 2022.
- Cartesian Therapeutics, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $1.34M, a 19.48% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $477.00K 10-Q · filed 2026-08-06 | $692.00K derived: sum of 3 quarters · filed 2026-08-06 | $884.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $235.00K 10-Q · filed 2026-04-30 | $450.00K derived: sum of 2 quarters · filed 2026-04-30 | $642.00K derived: sum of 3 quarters · filed 2026-04-30 | $829.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $407.00K derived: sum of 2 quarters · filed 2026-03-09 | $594.00K derived: sum of 3 quarters · filed 2026-08-06 | $778.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $379.00K derived: sum of 2 quarters · filed 2026-08-06 | $563.00K 10-Q · filed 2025-11-06 | $1.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $371.00K 10-Q · filed 2026-08-06 | $1.04M derived: sum of 3 quarters · filed 2026-08-06 | $1.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $184.00K 10-Q · filed 2026-04-30 | $855.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.51M derived: sum of 3 quarters · filed 2026-04-30 | $2.11M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $671.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.32M derived: sum of 2 quarters · filed 2026-03-09 | $1.93M derived: sum of 3 quarters · filed 2026-03-09 | $2.44M 10-K · filed 2026-03-09 |
| 2024-09-30 | $653.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.25M derived: sum of 2 quarters · filed 2025-11-06 | $1.77M 10-Q · filed 2025-11-06 | $2.24M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $601.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.11M 10-Q · filed 2025-08-07 | $1.59M derived: sum of 3 quarters · filed 2025-08-07 | $2.02M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $512.00K 10-Q · filed 2025-05-08 | $988.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.42M derived: sum of 3 quarters · filed 2025-05-08 | $1.85M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $476.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $912.00K derived: sum of 2 quarters · filed 2025-03-13 | $1.34M derived: sum of 3 quarters · filed 2025-03-13 | $1.75M 10-K · filed 2025-03-13 |
| 2023-09-30 | $436.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $862.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.28M 10-Q · filed 2024-11-07 | $1.69M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $426.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $842.00K 10-Q · filed 2024-08-08 | $1.25M derived: sum of 3 quarters · filed 2024-08-08 | $1.59M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $416.00K 10-Q · filed 2024-05-08 | $823.00K derived: sum of 2 quarters · filed 2024-05-08 | $1.16M derived: sum of 3 quarters · filed 2024-05-08 | $1.46M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $746.00K derived: sum of 2 quarters · filed 2024-03-07 | $1.04M derived: sum of 3 quarters · filed 2024-03-07 | $1.34M 10-K · filed 2024-03-07 |
| 2022-09-30 | $339.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $637.00K derived: sum of 2 quarters · filed 2023-11-13 | $930.00K 10-Q · filed 2023-11-13 | $1.22M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $298.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | $591.00K 10-Q · filed 2023-08-17 | $878.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.16M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $293.00K 10-Q · filed 2023-05-04 | $580.00K derived: sum of 2 quarters · filed 2024-03-07 | $863.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.14M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $570.00K derived: sum of 2 quarters · filed 2024-03-07 | $847.00K derived: sum of 3 quarters · filed 2024-03-07 | $1.12M 10-K · filed 2024-03-07 |
| 2021-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $560.00K derived: sum of 2 quarters · filed 2022-11-03 | $832.00K 10-Q · filed 2022-11-03 | $1.10M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $277.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $549.00K 10-Q · filed 2022-08-08 | $815.00K derived: sum of 3 quarters · filed 2023-03-02 | $1.07M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $272.00K 10-Q · filed 2022-05-05 | $538.00K derived: sum of 2 quarters · filed 2023-03-02 | $797.00K derived: sum of 3 quarters · filed 2023-03-02 | $1.03M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $525.00K derived: sum of 2 quarters · filed 2023-03-02 | $761.00K derived: sum of 3 quarters · filed 2023-03-02 | $1.13M 10-K · filed 2023-03-02 |
| 2020-09-30 | $259.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $495.00K derived: sum of 2 quarters · filed 2021-11-09 | $861.00K 10-Q · filed 2021-11-09 | $1.15M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $602.00K 10-Q · filed 2021-08-12 | $895.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.18M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $366.00K 10-Q · filed 2021-05-13 | $659.00K derived: sum of 2 quarters · filed 2022-03-10 | $944.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.22M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $578.00K derived: sum of 2 quarters · filed 2022-03-10 | $855.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.30M 10-K · filed 2022-03-10 |
| 2019-09-30 | $285.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $562.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.01M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $277.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $723.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $446.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-12 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |